ConductScience.org, home

Library / Trials

Sleep Health Enhancement in Midlife Adults

NCT06311500, Phase 1, Phase 2, Completed, University of Kansas Medical Center

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleSleep Health Enhancement in Midlife AdultsClinicalTrials.gov
NCT numberNCT06311500ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesPhase 1, Phase 2ClinicalTrials.gov
Enrollment30 participants, actualClinicalTrials.gov
Lead sponsorUniversity of Kansas Medical CenterClinicalTrials.gov
ConditionsSleep Health, Midlife AdultsClinicalTrials.gov
InterventionsSleep health enhancement interventionClinicalTrials.gov
First posted2024-03-15ClinicalTrials.gov
Last updated2025-12-26ClinicalTrials.gov

Registered outcomes 12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
Primary6-item Acceptability Scaleimmediately post-intervention5-point Likert scales on ease of use, understandability, enjoyment, perceived helpfulness, time commitment, and overall satisfactionClinicalTrials.gov
PrimaryQualitative interviewimmediately post-interventionsemi-structured interview to assess acceptabilityClinicalTrials.gov
PrimaryRu-SATED Composite scorebaseline, Week 6, Week 12Comprised of 6 subscores (regularity, timing, efficiency, and duration from actigraphy, satisfaction from sleep diary, and alertness from Epworth Sleepiness Scale)ClinicalTrials.gov
PrimarySleep Self-Efficacy Scalebaseline, Week 6, Week 129 item self-report Likert-scale questionnaire use to identify sleep self-efficacy.ClinicalTrials.gov
PrimaryPittsburgh Sleep Quality Indexbaseline, Week 6, Week 12used to assess quality of sleepClinicalTrials.gov
PrimaryEpworth Sleepiness Scalebaseline, Week 6, Week 12used to assess daytime sleepinessClinicalTrials.gov
PrimaryDysfunctional Beliefs About Sleep (DBAS-10) consists of 10 statements reflecting beliefs and attitudes about sleep. Each statement is rated from 1 = strongly disagree to 10 = strongly agreebaseline, Week 6, Week 12The DBAS-10 used to identify dysfunctional beliefs about sleepClinicalTrials.gov
PrimaryPositive Affect and Negative Affect Schedulebaseline, Week 6, Week 1220-item self-report questionnaire used to measure positive and negative emotionsClinicalTrials.gov
PrimaryContinuous Performance Testbaseline, Week 6, Week 12
requires participants to respond as quickly and accurately as possible to a series of stimuli that are delivered via computer. The participants will be instructed to tap the space bar for every letter except "X."
ClinicalTrials.gov
PrimaryStroop Testbaseline, Week 6, Week 12requires participants to inhibit the natural response (reading a word) and replace it with another response (saying a color)ClinicalTrials.gov
PrimaryCognitive Failures Questionnairebaseline, Week 6, Week 12assesses perception of cognitive abilities over the past 6 monthsClinicalTrials.gov
PrimaryActigraphybaseline, Week 6, Week 12Participants will wear an actigraph on their non-dominant wrist for 7 nights to assess sleep/wake cycle. Mains variables of interest are sleep regularity, timing, efficiency, and duration.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Continuous Performance TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)